Ami Fadia
Stock Analyst at Needham
(1.12)
# 1987
Out of 5,340 analysts
487
Total ratings
35.88%
Success rate
-5.70%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRUS Merus | Reiterates: Buy | 75 75 | 41.46 | 80.9% | 28 | May 19, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Strong Buy | 27 30 | 22.27 | 34.71% | 9 | May 19, 2025 | |
NMRA Neumora Therapeutics | Reiterates: Buy | 5 5 | 0.71 | 604.23% | 9 | May 13, 2025 | |
RVMD Revolution Medicines | Reiterates: Buy | 57 57 | 39.55 | 44.12% | 23 | May 8, 2025 | |
AVDL Avadel Pharmaceutica... | Reiterates: Buy | 19 19 | 9 | 111.11% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 6.25 | 332% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 200 | 108.98 | 83.52% | 30 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 49 49 | 35.07 | 39.72% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 138 139 | 120.92 | 14.95% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 37.08 | 115.75% | 11 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 29 29 | 8.18 | 254.52% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 40 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 133 130 | 101.69 | 27.84% | 30 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.47 | 716.33% | 15 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 153 153 | 107.49 | 42.34% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 27 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | n/a | n/a | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 28 26 | n/a | n/a | 6 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 320 | 10.58 | 2924.57% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 63 75 | 25.85 | 190.14% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 5 | n/a | n/a | 2 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 10 14 | n/a | n/a | 3 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 23 | 0.97 | 2219.59% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 63 | 27.02 | 133.16% | 4 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 2 | n/a | n/a | 8 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 10 | n/a | n/a | 2 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 24 | n/a | n/a | 8 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 20 | n/a | n/a | 2 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 5 | 3.28 | 52.44% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 5 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 1.98 | 1011.11% | 4 | Jan 3, 2018 |